SYNTHETIC NEUROPROTECTIVE GLUTAMATE RELEASE BLOCKERS

合成神经保护谷氨酸释放阻滞剂

基本信息

  • 批准号:
    2267723
  • 负责人:
  • 金额:
    $ 25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-12-17 至 1995-03-31
  • 项目状态:
    已结题

项目摘要

Brain damage in stroke and in cardiac arrest results from an inadequate supply of blood to the brain, termed brain ischemia. Brain ischemia depletes the energy stores of affected brain regions and causes the excessive release of glutamate and other neurotransmitters from metabolically compromised nerve terminals. Our goal is to discover synthetic, selective antagonists of the ion channels controlling the release of glutamate and other neurotransmitters. Such compounds may be employed as drugs to limit brain damage in focal ischemia (stroke) and global ischemia (resulting from cardiac arrest or complications of cardiac surgery). Using novel drug discovery methology based on a proprietary method for monitoring neurotransmitter release from brain nerve terminals, we have developed a novel compound series of synthetic glutamate release blockers, members of which are highly neuroprotective in an animal model of brain ischemia. During Phase II, we hope to incorporate rational drug design strategies resulting from knowledge on the structure of the site of interaction of these neuroprotective compounds with its ion channel targets. Candidates for drug development are likely to emerge from the Phase II project period, and selection of such candidates is the central goal of the project.
中风和心脏骤停造成的脑损伤是由于缺乏

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES B FISCHER其他文献

JAMES B FISCHER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES B FISCHER', 18)}}的其他基金

DITOLYL GUANIDINE ANALOGS AS ANTIPSYCHOTIC DRUGS
作为抗精神病药的二甲苯基胍类似物
  • 批准号:
    3509014
  • 财政年份:
    1989
  • 资助金额:
    $ 25万
  • 项目类别:
DITOLYL GUANIDINE ANALOGS AS ANTIPSYCHOTIC DRUGS
作为抗精神病药的二甲苯基胍类似物
  • 批准号:
    3509013
  • 财政年份:
    1989
  • 资助金额:
    $ 25万
  • 项目类别:
DITOLYL GUANIDINE ANALOGS AS ANTIPSYCHOTIC DRUGS
作为抗精神病药的二甲苯基胍类似物
  • 批准号:
    3503199
  • 财政年份:
    1989
  • 资助金额:
    $ 25万
  • 项目类别:
SCREENING ASSAY FOR EXCITATORY AMINO ACID ANTAGONISTS
兴奋性氨基酸拮抗剂的筛选测定
  • 批准号:
    3504298
  • 财政年份:
    1988
  • 资助金额:
    $ 25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了